CXCR4 and osteosarcoma: By contrast, a greater proportion of osteosarcoma samples exhibited CXCR4 and β-catenin expression [68.75% (66/96 cases) and 61.46% (59/96 cases), respectively; Fig. 1D–F; Table I].